Skip to main content
  • Bookmarks
  • Register
  • Login

NIH OIR/OTT Logo

Main Menu

  • Partnerships

    Partnerships

    These links provide access to the information that is commonly needed for companies or organizations interested in partnering with NIH. The information here covers the process from researching available technologies through fees associated.

    • Overview
    • Opportunities
    • Featured Technologies
    • Collaboration / CRADAs
    • Licensing Process
    • Forms / Model Agreements
    • Startups
    • Non-Profits
    • License Materials
    • Licensing FAQs
    • Business Opportunities
    • Product Showcase
    • Product Pipeline
    • Federal Register Notices

    The NIH cannot commercialize its discoveries even with its considerable size and resources — it relies instead upon partners. Typically, a royalty-bearing exclusive license agreement with the right to sublicense is given to a company from NIH to use patents, materials, or other assets to bring a therapeutic or vaccine product concept to market.

  • Royalties

    Royalties

    Information for inventors and licensees on the administration of royalties.

    • Information for NIH Inventors
    • Information for Licensees
    • License Notices / Reports
    • Royalty Coordinators
    • NIH Payment Center
    • CDC Payment Center

    Each year, hundreds of new inventions are made at NIH and CDC laboratories. Nine NIH Institutes or Centers (ICs) transfer NIH and CDC inventions through licenses to the private sector for further research and development and eventual commercialization.

  • Reports

    Reports

    These links provide access to reports tracking the success of NIH licensed products.

    • Annual Reports
    • Tech Transfer Statistics
    • Tech Transfer Metrics
    • Tech Transfer Awards
    • Commercial Outcomes
    • HHS License-Based Vaccines & Therapeutics
    • Stories of Discovery
    • Chen Lecture Videos
    • Public Health & Economic Impact Study
    • Media Room
    • Tech Transfer Newsletters
    • NIH Patents and Active Patent Commercialization Licenses

    The NIH, CDC and FDA Intramural Research Programs are exceptionally innovative as exemplified by the many products currently on the market that benefit the public every day. Reports are generated from the commonly tracked metrics related to these products.

  • Resources

    Resources

    These links provide resources to those interested in the technology transfer activities at NIH.

    • Forms and Model Agreements
    • License Notices / Reports
    • Video Library
    • Inventor Resources
    • Presentations & Articles
    • FAQs
    • RSS Feeds
    • Inventor Showcase

    Past videos, lectures, presentations, and articles related to technology transfer at NIH are kept and made available to the public. These topics range from general technology transfer information to processes specific to NIH.

  • Policy & Regulations

    Policies & Regulations

    These links provide access to the policies and regulations surrounding partnering or collaborating with NIH.

    • Freedom of Information Act (FOIA)
    • PHS Technology Transfer Policy
    • NIH IRP Access Planning Policy
    • Policies & Reports
    • Useful Links

    If a company would like to acquire rights to use or commercialize either an unpatented material, or a patented or patent-pending invention, a license is required. There are numerous policies and regulations surrounding the transfer or a technology from the NIH to a company or organization.

  • About

    About Us

    These links provide information about the Office of Technology Transfer.

    • Contact Us
    • Staff Directory
    • Management
    • FAQs
    • HHS Tech Transfer Offices & Contacts
    • Careers in Tech Transfer
    • Location & Directions
    • Feedback

    The NIH Office of Technology Transfer (OTT) plays a strategic role by supporting the patenting and licensing efforts of our NIH ICs. OTT protects, monitors, markets and manages the wide range of NIH discoveries, inventions, and other intellectual property as mandated by the Federal Technology Transfer Act and related legislation.

Breadcrumb

  1. Home
  2. Taxonomy
  3. Term
  4. NCI

METHODS FOR DETERMINING THE PRESENCE OF FUNCTIONAL p53 IN MAMMALIAN CELLS

  • Read more about METHODS FOR DETERMINING THE PRESENCE OF FUNCTIONAL p53 IN MAMMALIAN CELLS
Patent Cooperation Treaty
PCT/US1993/011026
Filed on 1993-11-12

PEPTIDE INHIBITORS OF FIBRONECTIN AND RELATED COLLAGEN BINDING- PROTEINS

  • Read more about PEPTIDE INHIBITORS OF FIBRONECTIN AND RELATED COLLAGEN BINDING- PROTEINS
Patent Cooperation Treaty
PCT/US1993/011104
Filed on 1993-11-09

DIAGNOSTIC REAGENTS AND THEIR USE IN THE DETECTION OF HUMAN HERPESVIRUS 7

  • Read more about DIAGNOSTIC REAGENTS AND THEIR USE IN THE DETECTION OF HUMAN HERPESVIRUS 7
Patent Cooperation Treaty
PCT/US1993/010106
Filed on 1993-10-21

TOPOISOMERASE II INHIBITORS AND THERAPEUTIC USES THEREFOR

  • Read more about TOPOISOMERASE II INHIBITORS AND THERAPEUTIC USES THEREFOR
Patent Cooperation Treaty
PCT/US1993/009629
Filed on 1993-10-14

TUMORICIDAL ACTIVITY OF BENZOQUINONOID ANSAMYCINS AGAINST PROSTATE CANCER AND PRIMITIVE NEURAL MALIGNANCIES

  • Read more about TUMORICIDAL ACTIVITY OF BENZOQUINONOID ANSAMYCINS AGAINST PROSTATE CANCER AND PRIMITIVE NEURAL MALIGNANCIES
Patent Cooperation Treaty
PCT/US1993/009858
Filed on 1993-10-14

MONOCLONAL ANTIBODIES TO PROSTATE CELLS

  • Read more about MONOCLONAL ANTIBODIES TO PROSTATE CELLS
Patent Cooperation Treaty
PCT/US1993/009166
Filed on 1993-09-22

LONG-TERM PROLIFERATION OF PRIMORDIAL GERM CELLS

  • Read more about LONG-TERM PROLIFERATION OF PRIMORDIAL GERM CELLS
Patent Cooperation Treaty
PCT/US1993/009536
Filed on 1993-10-06

USE OF TAXOL FOR TREATING LYMPHOMAS AND BREAST CANCER

  • Read more about USE OF TAXOL FOR TREATING LYMPHOMAS AND BREAST CANCER
Patent Cooperation Treaty
PCT/US1993/008983
Filed on 1993-09-22

A Method of Preventing Tumor Metastasis

  • Read more about A Method of Preventing Tumor Metastasis
Patent Cooperation Treaty
PCT/US1993/008531
Filed on 1993-09-15

A NOVEL B-LYMPHOMA CELL LINE AND ANTIGEN

  • Read more about A NOVEL B-LYMPHOMA CELL LINE AND ANTIGEN
Patent Cooperation Treaty
PCT/US1993/07856
Filed on 1993-08-20

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 1504
  • Page 1505
  • Page 1506
  • Page 1507
  • Page 1508
  • Page 1509
  • Page 1510
  • Page 1511
  • Page 1512
  • …
  • Next page ››
  • Last page Last »
Subscribe to NCI
NIH White Technology Transfer Logo

Return to Top

  • About
  • Privacy Notice
  • Accessibility
  • Web Policies & Notices
  • Open Data
  •  
  • For NIH Staff Only
  • HHS
  • NIH
  • HHS Vulnerability Disclosure
  • Connect
  • Twitter
  • LinkedIn
  • Contact
  • Feedback

Office of Technology Transfer, Office of Intramural Research, National Institutes of Health